By now it has become clear that the Coronavirus infection damages multiple organs like lungs, heart, brain, kidney, etc. In cases of long haul COVID, it becomes all the more crucial to watch out for any substantial damage to other organs of the body.
One of the most dreaded topics these days is the formation of blood clots in COVID patients. As of now, it is not very clear why COVID-19 patients develop blood clots. But we do know that the infection activates cells that are involved in the clotting process.
We know that these blood clots can be fatal. In some cases, these clots can cause heart
attacks and strokes. In some cases, they affect the lungs, liver, kidneys, etc.
The medical fraternity believes that the people who are at high risk of developing blood clots fall in either of these three categories:
1) Hospitalization: The patient had undergone hospitalization for treatment of the COVID-19 infection.
2) High D-Dimer: The patients who have high D-Dimer levels or other inflammatory markers are likely to develop blood clots.
3) Comorbidities: Patients with comorbidities like hypertension or diabetes are at risk of blood clot formation.
Having seen the morbidity and mortality COVID causes, it is recommended for everyone who has gotten affected to be careful and vigilant about long COVID symptoms and consult the specialists at the earliest to safeguard themselves.
At Ubiqare, we include thrombosis risk assessment and monitoring as a key service of our post COVID care service. We monitor the patient regularly to identify any early signs of blood clot formation. In case of any alarming signs, our specialists define the care protocol that is then delivered to the patient at home by our clinical team.
In addition to the clinical oversight, the risk of blood clotting can be reduced by:
Long COVID or long haul COVID symptoms should not be taken lightly. Get yourself assessed for long COVID and the associated risks today.